EDITORIAL: What's in store at MHRA under NICE man Rawlins?
This article was originally published in Scrip
Executive Summary
The appointment of Professor Sir Michael Rawlins as chair of the UK Medicines and Healthcare Products Regulatory Agency will capture the attention of anyone with even a passing interest in the future of drug and medical device regulation.